Delivery Order 36F79719D0247-36C26024F0563
Award Date
8/7/24
Potential Completion Date
11/5/24
Potential Value
Not listed
Federal Agency
Veterans Integrated Service Network 20
Awardee
Ucb, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price delivery order contract to Acorda Therapeutics, Inc., a biotechnology company specializing in therapies for neurological disorders. The contract, valued at $478,860.00, is for the supply of DALFAMPRIDINE, a medication used to treat Parkinson's disease and multiple sclerosis. The delivery order was placed under Acorda's existing Federal Supply Schedule (FSS) contract with the VA (36F79723D0194), valued at over $16.3...
This federal contract award is for the delivery of 1,000 mg/40 mL vials of the pharmaceutical product ZINPLAVA to the Defense Logistics Agency (DLA). The contract, valued at $2,465.44, is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a firm fixed-price pricing type and a completion date of November 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Lundbeck LLC, a global pharmaceutical company. The contract is for the provision of various pharmaceutical products used to treat neurological conditions common to the veteran population, including Sabril (vigabatrin) for treatment-resistant seizures, Xenazine (tetrabenazine) for chorea associated with Huntington's disease, and Northera (droxidopa)...
This federal contract award was issued by the Department of Veterans Affairs (VA) to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., a prominent pharmaceutical manufacturer. The $18,803.91 firm fixed price delivery order is for the oncology medication BALVERSA 4 MG, with a completion date of June 6, 2025. The award is part of a larger $3.1 billion multiple-award Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) held by Janssen Biotech Inc. with...
This is a $3,676.29 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides 60 tablets of the medication Viberzi 100 mg for an ultimate completion date of November 18, 2024. This award is part of an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $5,253.76 and is a Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA), a defense agency. The award is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is valued at $20,614.71 for the delivery of 4562671024 BRIVIACT 50 MG TABLET 60S. The contract was awarded on November 1, 2023 and has an ultimate completion date of November 2, 2023. It is a firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA), which is part of the Department of Defense. The contract is not designated as a set-aside and appears to be part of a larger Indefinite...
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological treatments. The contract, valued at $1,436,580.00, is for the supply of Dalfampridine 10mg tablets, a medication used to treat neurological disorders. The contract was awarded under Acorda's existing Federal Supply Schedule (FSS) contract with the VA, FSS-61-IB Pharmaceuticals and Drugs, which has a total ceiling...
This federal contract award, valued at $21,185.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The award covers the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of November...
This is a $4,084.23 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, with a period of performance through January 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...